Overexpression of fibrinogen-like protein 2 induces epithelial-to-mesenchymal transition and promotes tumor progression in colorectal carcinoma

Medical Oncology

Volumn 31, Issue 9, 2014, Pages 1-9

  Qin, Wen Zheng ^a   Li, Quan Lin ^a   Chen, Wei Feng ^a   Xu, Mei Dong ^a   Zhang, Yi Qun ^a   Zhong, Yun Shi ^a   Ma, Li Li ^a   Hu, Jian Wei ^a   Cai, Ming Yan ^a   He, Meng Jiang ^a   Yao, Li Qing ^a   Zhou, Ping Hong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; Epithelial to mesenchymal transition (EMT); Fibrinogen like protein 2

Indexed keywords

EID: 84905892901     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0181-7     Document Type: Article

References (26)

1. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522–31.
2. Zhu W, Cai MY, Tong ZT, et al. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial–mesenchymal transition. Gut. 2012;61:562–75.
3. Lubbe WJ, Zuzga DS, Zhou Z, et al. Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9. Cancer Res. 2009;69:3529–36.
4. Itatani Y, Kawada K, Fujishita T, et al. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Gastroenterology. 2013;145:1064–75.
5. Jackstadt R, Röh S, Neumann J, et al. AP4 is a mediator of epithelial–mesenchymal transition and metastasis in colorectal cancer. J Exp Med. 2014;210:1331–50.
6. Gao W, Chen L, Ma Z, et al. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential. Gastroenterology. 2013;145:636–46.
7. Schwitalla S, Ziegler PK, Horst D, et al. Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell. 2013;23:93–106.
8. Liang L, Li X, Zhang X, et al. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. Gastroenterology. 2013;144:624–35.
9. Liu X, Piela-Smith TH. Fibrin(ogen)-induced expression of ICAM-1 and chemokines in human synovial fibroblasts. J Immunol. 2000;165:5255–61.
10. Sitrin RG, Pan PM, Srikanth S, et al. Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J Immunol. 1998;161:1462–70.
11. Shalev I, Wong KM, Foerster K, et al. The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology. 2009;49:387–97.
12. Robertson M. Fgl2: link between hepatitis B and SARS? Drug Discov Today. 2003;8:768–70.
13. Foerster K, Helmy A, Zhu Y, et al. The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection. J Hepatol. 2010;53:608–15.
14. Chen Y, Wu S, Guo G, et al. Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection. PLoS Pathog. 2011;7:e1001347.
15. Li Q, Smith AJ, Schacker TW, et al. Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection. J Immunol. 2009;183:1975–82.
16. Liu Y, Xu L, Zeng Q, et al. Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis. Liver Int. 2012;32:1585–95.
17. Wang C, Jiang K, Kang X, et al. Tumor-derived secretory clusterin induces epithelial–mesenchymal transition and facilitates hepatocellular carcinoma metastasis. Int J Biochem Cell Biol. 2012;44:2308–20.
18. Wang C, Jiang K, Gao D, et al. Clusterin protects hepatocellular carcinoma cells from endoplasmic reticulum stress induced apoptosis through GRP78. PLoS One. 2013;8:e55981.
19. Fan S, Niu Y, Tan N, et al. LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump. Oncogene. 2013;32:1682–90.
20. Li QL, Gu FM, Gao Q, et al. Activation of PI3K/AKT and MAPK pathway through a PDGFRb-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma. PLoS One. 2012;7(3):e33379.
21. Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252–9.
22. Khattar R, Luft O, Yavorska N, et al. Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE. PLoS One. 2013;8(10):e72309.
23. Xu GL, Chen J, Yang F, et al. C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis via potentiating Fgl2/fibroleukin expression. Hepatology. 2014. doi:10.1002/hep.27114.
24. Su K, Chen F, Yan WM, et al. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma. World J Gastroenterol. 2008;14:5980–9.
25. Li C, Ma H, Wang Y, et al. Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. J Clin Invest. 2014. doi:10.1172/JCI71103.
26. Yokobori T, Iinuma H, Shimamura T, et al. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial–mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res. 2013;73(7):2059–69.